Oncology – Page 15 – Healthcare Data News

February 15, 2022February 21, 2022 AI Competitor News Oncology

AI & cancer: Big data, big gains for medicine

Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine The words artificial intelligence (AI) and ‘machine learning’ (ML) are likely familiar to...

February 9, 2022February 14, 2022 Collaborations Competitor News Oncology Pharma

Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

February 09, 2022 06:55 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and...

February 8, 2022February 14, 2022 Competitor News M&A Oncology

Tempus Announces the Acquisition of Highline Sciences

Tempus Announces the Acquisition of Highline Sciences February 08, 2022 08:00 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the acquisition of...

February 7, 2022 Industry News Oncology

Fact Sheet: President Biden Reignites Cancer Moonshot to End Cancer as We Know It

FEBRUARY 02, 2022•STATEMENTS AND RELEASES Biden-Harris Administration Sets Goal of Reducing Cancer Death Rate by at least 50 Percent Over the Next 25 Years, and Improving the Experience of Living...

February 5, 2022 Industry News Oncology

The Importance of Real-World Data in Cancer Care to Improve Patient Quality of Life

So much of cancer care is about time. When a clinician diagnoses a patient with cancer – particularly advanced cancer — there’s no time to waste. Treatment decisions that give...

February 3, 2022February 5, 2022 Collaborations Competitor News Oncology

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

CHICAGO, Feb. 3, 2022 /PRNewswire/ — EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced a strategic partnership with Integra Connect, LLC, designed to support life sciences...

February 2, 2022April 4, 2022 AI Clinical Trials Competitor News Ethics Oncology

Implementing Responsible AI to Drive Innovation in Clinical Research & Precision Medicine

by Prakriteswar Santikary, Ph.D., VP of Engineering and Technology at ConcertAI 01/24/2022 Researchers might be skeptical and, with people’s lives at stake, that’s understandable. Here’s how to take advantage of the...

January 26, 2022 Collaborations Competitor News International Japan Oncology

Flatiron Health Announces RWD Partnership With Japan’s NCCHE

January 26, 2022 07:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Flatiron HealthⓇ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal...

January 20, 2022January 25, 2022 Collaborations Competitor News Data Partnership Oncology

Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer

Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patient’s experience January 20, 2022 10:00 ET | Source: Syapse …...

January 20, 2022January 25, 2022 Competitor News Oncology RWE Study

Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD

Abstract Background: The CARD study demonstrated superiority of cabazitaxel over abiraterone/enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) who received prior docetaxel and progressed ≤12 months on the alternative androgen-receptor-targeted...